Antipsychotic Agents: all 1,683 studies that test it
Page 13 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUELCompletedNCT00832221Phase 1
- Risperidone 1 mg Tablet in Healthy Subjects Under Fasting ConditionsCompletedNCT00830349Phase 1
- Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed ConditionsCompletedNCT00829894Phase 1
- Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With SchizophreniaCompletedNCT00827840Phase 4
- Pharmacological Treatment of Children and Adolescents With Severe Mood DysregulationStatus unknownNCT00825552Not applicable
- Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With SchizophreniaStatus unknownNCT00825045Not applicable
- Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple MyelomaStatus unknownNCT00821301Phase 1
- 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET StudyCompletedNCT00818298Not applicable
- A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With SchizophreniaCompletedNCT00817648Phase 4
- Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in SchizophreniaCompletedNCT00797927Phase 4
- A Dose-proportionality Study of Five Tablet Strengths of ER OROS PaliperidoneCompletedNCT00796835Phase 1
- A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release FormulationsCompletedNCT00796471Phase 1
- As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release FormulationsCompletedNCT00796185Phase 1
- Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)Status unknownNCT00794625Phase 4
- A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ERCompletedNCT00791713Phase 1
- A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineCompletedNCT00791622Phase 1
- A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal FunctionCompletedNCT00791401Phase 1
- A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IRCompletedNCT00791193Phase 1
- A Study of the Dose Proportionality of Extended Release PaliperidoneCompletedNCT00791167Phase 1
- A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and VacavilleCompletedNCT00790777Phase 1
- Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized ChildrenCompletedNCT00790075Phase 4
- Ziprasidone vs Standard Therapy for Agitated Patients in the EDWithdrawnNCT00786318Phase 4
- Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With MirtazapineCompletedNCT00782405Phase 3
- Flushing in Social Anxiety Disorder on SeroquelCompletedNCT00773162Phase 3
- A Study in the Treatment of Acute ManiaTerminatedNCT00767715Phase 4
- Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of FibromyalgiaCompletedNCT00766350Phase 4
- Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)WithdrawnNCT00766064Phase 4
- Safety Study of an Antipsychotic, Sertindole, to Treat SchizophreniaCompletedNCT00763438Phase 4
- Efficacy Study on Cognitive Functions in Schizophrenic PatientsCompletedNCT00761670Phase 4
- Study on Metabolic Parameters of Sertindole in Patients With SchizophreniaCompletedNCT00759460Phase 3
- Exploratory Cognition Study of Sertindole in Patients With SchizophreniaCompletedNCT00759421Phase 3
- Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)CompletedNCT00753051Not applicable
- Quetiapine in the Treatment of Psychotic Depression - a Pilot StudyCompletedNCT00751504Phase 3
- To Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.Status unknownNCT00742638Not applicable
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine DependenceStatus unknownNCT00737256Phase 2
- Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer PainWithdrawnNCT00737191Not applicable
- Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsTerminatedNCT00734435Phase 2
- Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive DisorderCompletedNCT00733668Phase 2
- Aripiprazole for Methamphetamine Dependence: Double Blind Placebo TrialWithdrawnNCT00728312Phase 4
- Quetiapine Extended Release (XR) for the Treatment of Menopausal DepressionCompletedNCT00723970Phase 4
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
- Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation ComparisonCompletedNCT00702676Phase 1
- Role of Droperidol in Postoperative VomitingCompletedNCT00702442Phase 4
- Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement SurgeryCompletedNCT00699946Not applicable
- Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy SubjectsCompletedNCT00689559Phase 1
- Quetiapine in Co-Morbid Depressive and Anxiety DisordersCompletedNCT00688818Not applicable
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical TrialCompletedNCT00678457Phase 2
- Ziprasidone for Severe Conduct and Other Disruptive Behavior DisordersCompletedNCT00676429Phase 2
- A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia SyndromeCompletedNCT00675896Phase 4
- Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)CompletedNCT00672659Phase 2
- Cardio Risk of Acute Schizophrenia Olanzapine DukeWithdrawnNCT00672464Phase 4
- A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.CompletedNCT00668837Phase 3
- Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaCompletedNCT00654706Phase 3
- A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
- A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective DisorderCompletedNCT00650429Phase 4
- A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsCompletedNCT00649844Phase 3
- A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsCompletedNCT00649064Phase 4
- Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00648921Phase 1
- Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mgCompletedNCT00648778Phase 1
- Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mgTerminatedNCT00647972Phase 1
- Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00647777Phase 1
- A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic SchizophreniaTerminatedNCT00645515Phase 3
- Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.CompletedNCT00645502Phase 1
- A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese PatientsCompletedNCT00645372Phase 3
- A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous StudyCompletedNCT00645320Phase 4
- A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective DisorderTerminatedNCT00645229Phase 3
- A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
- Effects of Modafinil on Olanzapine Weight GainCompletedNCT00636896Not applicable
- Ziprasidone in the Treatment of Borderline Personality DisorderCompletedNCT00635921Phase 2
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
- Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality DisorderStatus unknownNCT00633802Not applicable
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and TiaprideCompletedNCT00632645Phase 3
- The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic PatientsTerminatedNCT00629252Not applicable
- The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)Status unknownNCT00626613Phase 4
- Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy HumansCompletedNCT00625170Not applicable
- Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy HumansCompletedNCT00625014Not applicable
- The Effects of the Anti Nausea Drugs Droperidol and Ondansetron on the Way the Heart Recovers Between BeatsCompletedNCT00624208Not applicable
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive DyskinesiaCompletedNCT00621998Phase 4
- Seroquel- Agitation Associated With DementiaCompletedNCT00621647Phase 3
- The Effect of Sertindole on Sensory Gating and Cognition in Healthy VolunteersCompletedNCT00612079Not applicable
- An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)TerminatedNCT00606541Early Phase 1
- Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care PatientsTerminatedNCT00599287Phase 3
- Olanzapine in the Treatment of Anorexia NervosaCompletedNCT00592930Phase 4
- A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site StudyTerminatedNCT00584688Phase 2
- Prochlorperazine vs Imitrex for Acute Migraine in the Emergency DepartmentWithdrawnNCT00573599Not applicable
- Optimal Duration of Olanzapine Add-on Therapy in Major DepressionWithdrawnNCT00568672Phase 3
- Methamphetamine-Quetiapine Interactions in HumansTerminatedNCT00567866Early Phase 1
- Remediation of Schizophrenia Sensory Gating Deficit With AripiprazoleStatus unknownNCT00567099Not applicable
- Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder PatientsCompletedNCT00564564Phase 4
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot StudyCompletedNCT00561587Phase 2
- A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.CompletedNCT00558298Phase 3
- Quetiapine Induced Neuroplasticity in First-episode Schizophrenic PatientsCompletedNCT00554658Phase 4
- A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female SubjectsCompletedNCT00549666Phase 1
- Abilify in Bipolar Disorder for 24 Weeks Treatment EffectivenessCompletedNCT00545675Phase 4
- Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic AgentsCompletedNCT00545467Phase 4
- Abilify in Bipolar Disorder for 6 Weeks Treatment EffectivenessCompletedNCT00545142Phase 4
- Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and DyslipidemiaStatus unknownNCT00541554Phase 4
- Benzamide Derivates as Treatment of Clozapine-induced HypersalivationCompletedNCT00534573Phase 3
- Metabolic Profile and Anthropometric Changes in SchizophreniaCompletedNCT00534183Not applicable
- An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentCompletedNCT00526877Phase 4